Ziaee Amir, Oveisi Sonia, Ghorbani Azam, Hashemipour Sima, Mirenayat Maryamsadat
Department of Community Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Glob J Health Sci. 2012 Nov 30;5(1):187-92. doi: 10.5539/gjhs.v5n1p187.
The aim of this study was to assess the association between premicroalbuminuria and metabolic syndrome in women with Polycystic Ovary Syndrome (PCOS).
In this case - control study, we analyzed the medical records of 78 women (mean age ±SD was 27.2± 2.5 years) with PCOS and 63 controls (mean age ±SD was 26.9±2.4 years) from an endocrinology outpatient center of Buali university hospital Qazvin city in Iran during 2008 to 2010. Anthropometric characteristics, Albumin/Creatinine Ratio (ACR), Lipid profile, Liver enzyme concentration and occurrence of metabolic syndrome were compared between the two groups. Premicroalbuminuria was defined as ACR>7mg/g.
Premicroalbuminuria was found in 53.8% of PCOS and 33.3% of control group (p value=0.015). Patients with PCOS and premicroalbuminuria had higher serum levels of fasting insulin and glucose, blood pressure and more waist circumference compared to PCOS patients who had ACR<7mg/g. Fifty percent of patients with PCOS and ACR>7mg/g fulfilled criteria of metabolic syndrome; whereas no case of metabolic syndrome was found in PCOS patients without premicroalbuminuria.
Premicroalbuminuria is more prevalent in patients with PCOS compared to normal individuals. Metabolic syndrome is more frequently seen in patients with PCOS and premicroalbuminuria against patients with ACR<7mg/g.
本研究旨在评估多囊卵巢综合征(PCOS)女性患者微量白蛋白尿前期与代谢综合征之间的关联。
在这项病例对照研究中,我们分析了2008年至2010年期间伊朗加兹温市布阿利大学医院内分泌门诊中心的78例PCOS女性患者(平均年龄±标准差为27.2±2.5岁)和63例对照者(平均年龄±标准差为26.9±2.4岁)的病历。比较了两组的人体测量学特征、白蛋白/肌酐比值(ACR)、血脂谱、肝酶浓度和代谢综合征的发生情况。微量白蛋白尿前期定义为ACR>7mg/g。
PCOS组中53.8%的患者和对照组中33.3%的患者存在微量白蛋白尿前期(p值=0.015)。与ACR<7mg/g的PCOS患者相比,患有微量白蛋白尿前期的PCOS患者空腹胰岛素和血糖水平更高、血压更高且腰围更大。50%的ACR>7mg/g的PCOS患者符合代谢综合征标准;而在无微量白蛋白尿前期的PCOS患者中未发现代谢综合征病例。
与正常个体相比,微量白蛋白尿前期在PCOS患者中更为普遍。与ACR<7mg/g的患者相比,患有微量白蛋白尿前期的PCOS患者更易出现代谢综合征。